According to Zhitong Finance App, Tiger Pharmaceuticals (03347) issued an announcement. In order to enable the company and its subsidiaries (including domestic and foreign wholly-owned and holding subsidiaries directly or indirectly owned by the company) to more efficiently coordinate domestic and foreign capital and further support overseas business development, the company plans to use Tiger Pharmaceuticals as the host company to carry out cross-border fund pool settlement services at banks with international settlement business capabilities.

Through the development of cross-border fund pool settlement services, the company and domestic and foreign subsidiaries included in the fund pool will achieve centralized management and unified scheduling of cross-border RMB and foreign currency funds, effectively transfer and collect surplus funds, and improve the efficiency of the company's internal fund allocation. This move is conducive to reducing the cost of using capital and improving the efficiency of capital use, while strengthening the security control of overseas funds, optimizing overall business processes, and providing more flexible and efficient financial support for the collaborative development of the company's domestic and foreign business.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.